Cite Filings / FHTX / 0001193125-20-281152

Feed Companies Filings Check

Sign in

SC 13D

Beneficial Ownership Report

Foghorn Therapeutics Inc. Filed 2020-10-29 Acc 0001193125-20-281152

Documents 1

SC 13D Beneficial Ownership Report , d36897dsc13d.htm

Around this filing

2020-10-29 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2020-10-29 SC 13D Beneficial Ownership Report
2020-10-29 4 Chief Scientific Officer bought 5,500 shares at $16.00 ($88,000)
2020-10-29 4 See Remarks acquired 25,225 shares (conversion)
2020-10-29 4 10% owner bought 150,000 shares at $16.00 ($2,400,000)
2020-10-28 4 Former 10% Owner bought 150,000 shares at $16.00 ($2,400,000)
2020-10-27 8-K Bylaws or fiscal year change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d36897dsc13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…